To evaluate the utility of standard postoperative visit (POV) intervals in pars plana vitrectomy (PPV) as a function of adverse events (AEs) identified.
(POD1) visit, has been called into question. [1] [2] [3] The current standard of care after uncomplicated vitreoretinal surgery is POD1, week 1 (POW1), month 1 (POM1), and month 3 standard (s-POV) examinations. One of the primary goals of the POD1 visit is to assess for elevated intraocular pressure (IOP). [4] [5] [6] Additional early adverse events (AEs) can also be detected, including hypotony, choroidal effusion or hemorrhage, retinal detachment (RD), and endophthalmitis-all of which are vision threatening if left untreated. 7 Recent literature indicates that the intervention rate after vitrectomy in the immediate postoperative period ranges from 0.7% to 3.7%, which is similar to the POD1 intervention rate after routine cataract surgery (2.8%). [1] [2] [3] 8 Previous studies have reported postoperative outcomes on 20-and 23-gauge PPV, with fewer studies reporting postoperative outcomes of 25-and 27-gauge PPV. [9] [10] [11] [12] [13] We hypothesized that the later POVs-months 1 to 3-were an anachronism from an earlier time period characterized by larger-gauge surgery, longer surgery times, and inadequate visualization of the peripheral retina. [14] [15] [16] [17] In light of the improved surgical technique, we would expect a decreased AE rate at later POVs that would be both clinically and statistically significant for patients undergoing PPV. Based on these factors, we conducted a retrospective chart review of patients undergoing 23-, 25-, and 27-gauge PPV to evaluate the incidence of postoperative AEs and their treatment in an attempt to find a subset of patients who may not require later POVs.
METHODS
This study was conducted in compliance with the Health Insurance Portability and Accountability Act, and approval was obtained from the Institutional Review Board of the Stanford Hospital's subcommittees for the protection of human subjects. A retrospective cohort study was conducted on patients who underwent PPV at the Byers Eye Institute of Stanford University School of Medicine between January 1, 2016 and December 31, 2016. Patients who underwent PPV were identified using CPT, ICD-9, and ICD-10 codes. Exclusion criteria included patients younger than 18 years, patients with incomplete records (including patients with less than 2 POVs), and patients receiving nonvitreoretinal ocular surgery that could confound follow-up results.
To allow the maximum inclusion of AEs, any finding that was not seen after routine PPV or required monitoring was considered abnormal and recorded as an AE even if no intervention was undertaken. Patients were categorized into 3 groups. Group 1 included any patient that did not deviate from the traditional s-POV even if an AE occurred; group 2 included those who deviated from s-POV and adjusted based on physician discretion Postoperative Adverse Events, Interventions, and the Utility of Routine Follow-Up After 23-, 25-, and 27-Gauge Pars Plana Vitrectomy (a-POV); and group 3 included those who deviated from s-POV based on patient discretion (p-POV).
In this study, an IOP above 30 mm Hg was considered a significant AE. Hypotony was defined as an IOP less than 5 mm Hg. In cases without recorded IOP, a clinical diagnosis of hypotony was considered sufficient for inclusion. Adverse events were counted once per surgical follow-up period, even if their presence was noted at sequential visits.
Patient data were compiled and analyzed using Statistical Analysis Software Enterprise Guide Version 7.1 (SAS Institute, Cary, NC, US). Relative risks with corresponding 95% confidence intervals were obtained to determine the risk of AEs associated with demographic factors, preoperative diagnoses, and surgeries performed. Kaplan-Meier time-to-event analyses were used to assess the time to AEs between exposure variables. Statistical tests were performed using the appropriate parametric (χ 2 ) and nonparametric (Fisher exact, McNemar exact) tests. P values less than 0.05 were considered significant.
RESULTS

Study Cohort
A total of 283 patients underwent PPV between January 1, 2016 and December 31, 2016. Fifteen were excluded due to insufficient records, 11 owing to younger than 18 years, and 1 due to concurrent primary ruptured globe exploration. A total of 310 PPVs in 256 patients were included in this analysis.
Baseline Characteristics
Baseline characteristics are listed in Table 1 . Approximately 
Preoperative Diagnoses and Surgical Procedures
The most common indications for vitrectomy were RD (99, 31.9%), epiretinal membrane (ERM) (65, 21.0%), and VH (53, 17.1%). Glaucoma was present in 47 (15.2%) of patients, with 13 of those having previously undergone prior glaucoma surgery. Ten eyes had active endophthalmitis, and 1 eye had a history of treated endophthalmitis. Ten eyes had a diagnosis of posterior uveitis, which included idiopathic vitritis, panuveitis, progressive outer retinal necrosis, toxoplasmosis chorioretinitis, and a history of acute retinal necrosis. Six eyes had a diagnosis of von Hippel Lindau syndrome. The remaining preoperative diagnoses are listed in Table 2 . Of the 310 PPVs, 85.2% were 25-gauge, 11.9% were 27-gauge, and 2.9% were 23-gauge. One case used a combination of 25-and 27-gauge vitrectomy. Combined PPV and SB was performed in 30 (9.7%) eyes. Concurrent phacoemulsification with intraocular lens (IOL) insertion was performed in 26 (8.4%) eyes. Twenty patients underwent 'manipulation of IOL' which included explantation, repositioning, exchange, or secondary insertion of an anterior chamber (AC) IOL or posterior chamber IOL. The complete list of surgical procedures performed is shown in Table 3 .
Postoperative Adverse Events and Interventions
A total of 1203 POVs were reviewed. On average, a patient was seen 3.9 (median, 4) times in the first 3 months (range, 2−12 visits). The most common postoperative AEs in descending order of frequency were elevated IOP (12.3%), cystoid macular edema (CME) (6.1%), RD (5.8%), VH (5.2%), and hypotony (4.8%). All other AEs occurred at a frequency of less than 3% ( Table 4) . The most frequent type of AEs varied depending on the time after surgery. A total of 34 (10.9%) vitrectomies required repeated operation with the most common being for RD.
Patients in group 1 (s-POV) had an overall lower rate of AEs (61/212, 28.8%) compared with group 2 (a-POV) (43/68, 63.2%, P < 0.001) and group 3 (p-POV) (21/30, 70.0%, P < 0.001) (Fig.  1 ). There was no statistically significant difference in the overall rate of AEs when comparing group 2 and group 3. There was a statistically significant difference (P = 0.004) in the AEs between the groups only at the POD5-10 window (Fig. 1) . Adverse events Fig. 2A) . Vitrectomy gauge size did not result in a statistically significant difference in time to AE by Kaplan-Meier survival analysis (P = 0.733) (Fig. 2B) . On the other hand, there was a statistically significant reduction of all AEs among those undergoing isolated macular surgery (P < 0.001) and time to AE by Kaplan-Meier survival analysis (P < 0.0001) (Fig. 2C) . Of those undergoing macular surgery, there were 54 isolated ERM peels, 20 macular hole repairs, and 11 combined ERM peel and MH repairs. On POD1, 5 (5.9%) patients had AEs (all related to hypotony or elevated IOP). Four more patients had IOP-related AEs on their second POV. Of the 64 isolated macular PPVs with 3 or more visits and no AEs on their first 2 visits, only 2 had late AEs. One patient returned to clinic POD11 after ERM peel and was found to have worsening of CME, which resolved by the POM1 visit. The second patient developed diabetic macular edema on her POM1 visit and was treated with intravitreal bevacizumab.
Elevated IOP was the most common AE throughout the entire postoperative period (Table 4) . Of the 12 patients diagnosed with elevated IOP on POD1, 11 were treated with IOP-lowering medications alone, but 1 required an AC tap for an IOP of 41 mm Hg. Six patients were diagnosed with hypotony on POD1 visit-1 had a tube shunt placed at the time of the surgery, 2 were eventually diagnosed with ciliary body shutdown, and 1 was found to have a small wound leak that self-sealed. Two patients required injection of sterile air in the clinic and 1 of them was brought back to the operating room on POD2 to confirm closure of vitrectomy ports. Vitrectomy gauge was not associated with hypotony (P = 0.82).
Cystoid macular edema was the most common late AE with a peak incidence of 6.8% at POD68-90. Of those with postoperative CME, 26.3% (5/19) had a preoperative diagnosis of CME and 10.5% (2/19) had a preoperative diagnosis of proliferative diabetic retinopathy. Treatment for CME was topical steroids and/ or nonsteroidal anti-inflammatory drops in 9 patients, intravitreal anti-vascular endothelial growth factor agents in 7 patients, and intravitreal triamcinolone in 3 patients. Postoperative RD was seen in 18 patients. Of them, 15 had prior RDs, 2 had prior endophthalmitis (1 after ruptured globe endophthalmitis), and 1 occurred 6 weeks after PPV for nonclearing VH for Terson syndrome. 
DISCUSSION
The safety of vitreoretinal surgery has improved over the past several decades. However, the current standard of postoperative monitoring is still based on data from the 1980s. These studies showed that a high percentage of vitrectomy patients required inpatient care, mostly for recovery from general anesthesia.
14 Due to advances in vitrectomy equipment and the increasingly frequent use of local over general anesthesia, serious postoperative AEs have become less common. 15, 16 Data from this study suggest that patients undergoing uncomplicated macular surgery may not require a POM1 visit. In addition, patients who were placed on a standard postoperative evaluation schedule were less likely to have AEs than those where the physician or patient requested a more intensive follow-up schedule.
Multiple studies have reported on the incidence of early postoperative IOP elevation after PPV. Although rarely used anymore, 20-gauge sutured PPV is associated with the highest rate of IOP elevation and IOP instability, particularly in comparison with 23-gauge PPV 9,10,17,18 and 25-gauge PPV. 11, 19, 20 A recent study of 27-gauge PPV has reported a low incidence of postoperative IOP spikes. 13 This review of 23-, 25-, and 27-gauge PPV found an elevated IOP in 3.9% at POD1, which is similar to rates reported in current literature (0.7%−10.2%).
1-3 Notably, there were a significant proportion of patients with late IOP spikes (Table 4) , although most of these were associated with secondary etiologies including steroid-induced, neovascular glaucoma and pupillary block/angle closure secondary to gas or oil tamponade. Nevertheless, a normal POD1 and POW1 IOP did not preclude IOP elevation at later visits, especially in patients undergoing surgery for proliferative diabetic retinopathy or those requiring silicone oil.
In this cohort, POD1 hypotony occurred in 1.9% of patients, which is similar to other studies (1.8%-9.2%).
1,5,13,17 These studies have shown that hypotony often resolves within 1 to 2 weeks for 20-, 23-, and 27-gauge vitrectomies. 5, 13, 17 Two patients in the present review required reoperation for hypotony in the first week. Neither of these patients were found to have a wound leak, and ciliary body shutdown was implicated.
Reports of postoperative RD after PPV have also been low and varied depending on gauge size. The rate of RD after 20-gauge vitrectomy in previous studies has ranged between 1.7% and 14%.
21-23 For 23-gauge vitrectomies, the incidence of postoperative RD ranges from 0.2% to 2%. 5, 24, 25 The rate of RD in 25-gauge PPV has been reported as 2% to 2.2%. 11, 12 The incidence of RD in this review was 5.8% and peaked at POD 11 to 21 days.
With the continued emphasis on cost-effective health care, there has been a push towards eliminating unnecessary POVs.
1-3
Alexander et al 1 found that POD1 examinations of their 273 patients culminated in changes in medication in 6 (2%) due to IOP greater than 30 mm Hg and hypotony, and reoperation in 4 (1.5%) due to a flat AC, hyphema, nuclear fragment in the AC, and intraocular foreign body. Brennan et al 2 conducted a study of 176 23-gauge vitrectomies with planned POD1 follow-up and found that 8 (4.5%) had IOP greater than 40 mm Hg and 2 (1%) required surgical intervention (1 for hypotony due to a single sclerotomy leak and 1 for severe pain due to silicone oil overfill). Zick and Joondeph 3 reported on 134 PPVs where only 1 patient required an intervention (vitreous tap for gas overfill) on POD1. In response to the low intervention rate, those authors no longer conduct routine POD1 follow-up visits.
Based on the present data, the need for routine POD1 evaluation remains equivocal. In this study, 3.9% of patients had IOP greater than 30 mm Hg, and 3 patients required procedural intervention [1 patient required an AC tap (IOP, 41 mm Hg) and 2 patients required an injection of sterile air for hypotony]. Our data suggest that elimination of the POW1 visit is not indicated, given the higher incidence of AEs across all 3 groups (Table 4 , Fig. 1 ). However, our data suggest that the POM1 visit can be eliminated in patients undergoing isolated macular surgery and who do not have AEs at the POD1 or POW1 visit. Few studies have reported the AE rate after macular surgery with none indicating that it would be safe to eliminate the POM1 follow-up visit.
26,27
The comparison of standard postoperative follow-up (group 1), physician-directed follow-up periods (group 2), and patientdirected follow-up requests (group 3) provides a distinct clinical window into scheduling. The findings suggest that physicians and patients are capable of identifying early AEs or settings in which AEs are more likely. This may also reveal that patients who are deemed to require only standard follow-up may require less intensive evaluation. Clinical judgment is required in these cases, as there is a wide variability in patients' ability to identify symptoms that suggest possible AEs.
This report is not without limitations. The retrospective design precluded definitive establishment of causation and prevented standardized documentation of postoperative AEs. In addition, the small number of patients undergoing 23-and 27-gauge PPV precluded more robust statistical analysis of our findings. This study was conducted at a tertiary referral center and may suffer from referral bias. Specifically, there was a relatively high proportion of complex vitreoretinal surgeries and rare diagnoses, including 6 eyes with von Hippel Lindau syndrome during the study period. These findings are likely to have artificially elevated AE rates.
The data in this review suggest that the current standard schedule for follow-up visits may be tailored to the patient depending on the surgery performed. Specifically, patients undergoing standard macular surgery may require less frequent postoperative evaluation, whereas those undergoing more complex vitreoretinal surgery, including RD repair and secondary lens surgery, may require more frequent evaluations. 
